CGEN 内幕交易
CGEN 的 SEC Form 4 内幕交易记录
总交易
62
买入
0
买入总额
-
卖出总额
$184K
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(38) | OPHIR ERAN | President and CEO | 卖出 | 5,000 | $3.20 | $16K | 2026-04-24 | CEO卖出, 董事卖出 |
| ★★★★★(38) | OPHIR ERAN | President and CEO | 卖出 | 5,625 | $2.21 | $12K | 2026-04-01 | CEO卖出, 董事卖出 |
| ★★★★★(30) | OPHIR ERAN | President and CEO | 卖出 | 5,000 | $2.76 | $14K | 2026-04-14 | CEO卖出, 董事卖出 |
| ★★★★★(16) | LEVINE ZURIT | SVP, Business Development | 卖出 | 11,875 | $2.04 | $24K | 2026-03-26 | 高管卖出, 减持超20%持仓 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 1,875 | $2.50 | $5K | 2026-07-09 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,000 | $3.20 | $6K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 4,000 | $2.92 | $12K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,000 | $2.76 | $6K | 2026-04-14 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 3,125 | $2.56 | $8K | 2026-04-10 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,000 | $2.48 | $5K | 2026-04-10 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 5,375 | $2.42 | $13K | 2026-04-08 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,500 | $2.30 | $6K | 2026-04-07 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 3,500 | $2.20 | $8K | 2026-04-01 | 高管卖出 |
| ★★★★★(8) | LEVINE ZURIT | SVP, Business Development | 卖出 | 24,375 | $2.06 | $50K | 2026-03-26 | 高管卖出 |
| ★★★★★(0) | ZWEIFACH SANFORD S | - | 卖出 | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | HALEVY GILEAD | - | 卖出 | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | KREDO RUSSO SHARON | SVP, Research & Discovery | 卖出 | 24,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | FERRE PIERRE | Chief Operating Officer | 卖出 | 70,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | HUKKELHOVEN MATHIAS | - | 卖出 | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | MAHLER MICHELLE | Chief Medical Officer | 卖出 | 18,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 | 200,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | HUKKELHOVEN MATHIAS | - | 卖出 | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | LIVNAT SAVITZKY KINNERET | - | 卖出 | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | PERRY ERAN | - | 卖出 | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | ZWEIFACH SANFORD S | - | 卖出 | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | SILBERMAN DAVID | Chief Financial Officer | 卖出 | 19,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 18,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | PERRY ERAN | - | 卖出 | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | MAHLER MICHELLE | Chief Medical Officer | 卖出 | 13,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 24,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | KREDO RUSSO SHARON | SVP, Research & Discovery | 卖出 | 18,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | HALEVY GILEAD | - | 卖出 | 10,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | COHEN-DAYAG ANAT | - | 卖出 | 100,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | SILBERMAN DAVID | Chief Financial Officer | 卖出 | 26,000 | - | - | 2026-07-29 | |
| ★★★★★(0) | LIVNAT SAVITZKY KINNERET | - | 卖出 | 7,500 | - | - | 2026-07-29 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 1,875 | - | - | 2026-07-09 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,000 | $1.15 | $2K | 2026-04-24 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 | 5,000 | $0.83 | $4K | 2026-04-24 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,000 | - | - | 2026-04-14 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 | 5,000 | $0.83 | $4K | 2026-04-14 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,000 | $1.15 | $2K | 2026-04-10 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 1,125 | - | - | 2026-04-10 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 1,000 | - | - | 2026-04-08 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 4,375 | - | - | 2026-04-08 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,500 | $0.83 | $2K | 2026-04-07 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 | 5,625 | - | - | 2026-04-01 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 2,500 | $0.83 | $2K | 2026-04-01 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 1,000 | - | - | 2026-04-01 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 11,875 | - | - | 2026-03-26 | |
| ★★★★★(0) | LIVNAT SAVITZKY KINNERET | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | COHEN-DAYAG ANAT | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | HUKKELHOVEN MATHIAS | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | KREDO RUSSO SHARON | SVP, Research & Discovery | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | HALEVY GILEAD | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | HOLCOMB MICHELE | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | PERRY ERAN | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | MAHLER MICHELLE | Chief Medical Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | OPHIR ERAN | President and CEO | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | ZWEIFACH SANFORD S | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | FERRE PIERRE | Chief Operating Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LEVINE ZURIT | SVP, Business Development | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | SILBERMAN DAVID | Chief Financial Officer | 卖出 | 0 | - | - | 2026-03-18 |